These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17016778)

  • 21. Nuclease resistant methylphosphonate-DNA/LNA chimeric oligonucleotides.
    Nagahama K; Veedu RN; Wengel J
    Bioorg Med Chem Lett; 2009 May; 19(10):2707-9. PubMed ID: 19375912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Filling the gap in LNA antisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4'-C-hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmer.
    Fluiter K; Mook OR; Vreijling J; Langkjaer N; Højland T; Wengel J; Baas F
    Mol Biosyst; 2009 Aug; 5(8):838-43. PubMed ID: 19603119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Energetic aspects of locked nucleic acids quadruplex association and dissociation.
    Petraccone L; Erra E; Randazzo A; Giancola C
    Biopolymers; 2006 Dec; 83(6):584-94. PubMed ID: 16944520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Locked nucleic acid molecular beacons.
    Wang L; Yang CJ; Medley CD; Benner SA; Tan W
    J Am Chem Soc; 2005 Nov; 127(45):15664-5. PubMed ID: 16277483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five- and six-membered conformationally locked 2',4'-carbocyclic ribo-thymidines: synthesis, structure, and biochemical studies.
    Srivastava P; Barman J; Pathmasiri W; Plashkevych O; Wenska M; Chattopadhyaya J
    J Am Chem Soc; 2007 Jul; 129(26):8362-79. PubMed ID: 17552524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Locked nucleic acid oligonucleotides: the next generation of antisense agents?
    Grünweller A; Hartmann RK
    BioDrugs; 2007; 21(4):235-43. PubMed ID: 17628121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An LNA-based loss-of-function assay for micro-RNAs.
    Naguibneva I; Ameyar-Zazoua M; Nonne N; Polesskaya A; Ait-Si-Ali S; Groisman R; Souidi M; Pritchard LL; Harel-Bellan A
    Biomed Pharmacother; 2006 Nov; 60(9):633-8. PubMed ID: 16962735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AEG-35156, an antisense oligonucleotide against X-linked inhibitor of apoptosis for the potential treatment of cancer.
    Tamm I
    Curr Opin Investig Drugs; 2008 Jun; 9(6):638-46. PubMed ID: 18516763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of locked nucleic acids to improve aptamer in vivo stability and targeting function.
    Schmidt KS; Borkowski S; Kurreck J; Stephens AW; Bald R; Hecht M; Friebe M; Dinkelborg L; Erdmann VA
    Nucleic Acids Res; 2004; 32(19):5757-65. PubMed ID: 15509871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals.
    Campbell MA; Wengel J
    Chem Soc Rev; 2011 Dec; 40(12):5680-9. PubMed ID: 21556437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicology of antisense therapeutics.
    Jason TL; Koropatnick J; Berg RW
    Toxicol Appl Pharmacol; 2004 Nov; 201(1):66-83. PubMed ID: 15519609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antisense oligonucleotides: a new therapeutic approach].
    Guinot P; Temsamani J
    Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent single stranded RNA inhibition.
    Koch T
    Nucleic Acids Symp Ser (Oxf); 2008; (52):45. PubMed ID: 18776245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syntheses and base-pairing properties of locked nucleic acid nucleotides containing hypoxanthine, 2,6-diaminopurine, and 2-aminopurine nucleobases.
    Koshkin AA
    J Org Chem; 2004 May; 69(11):3711-8. PubMed ID: 15153000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural characterization of LNA and alpha-L-LNA hybridized to RNA.
    Petersen M; Nielsen JT; Bondensgaard K; Wengel J; Jacobsen JP
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1691-3. PubMed ID: 14565497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LNA-modified oligonucleotides effectively drive intramolecular-stable hairpin to intermolecular-duplex state.
    Kaur H; Wengel J; Maiti S
    Biochem Biophys Res Commun; 2007 Jan; 352(1):118-22. PubMed ID: 17107660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locked nucleic acid (LNA)-modified dinucleotide mRNA cap analogue: synthesis, enzymatic incorporation, and utilization.
    Kore AR; Shanmugasundaram M; Charles I; Vlassov AV; Barta TJ
    J Am Chem Soc; 2009 May; 131(18):6364-5. PubMed ID: 19385620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleic acid therapeutics for hematologic malignancies--theoretical considerations.
    Opalinska JB; Kalota A; Chattopadhyaya J; Damha M; Gewirtz AM
    Ann N Y Acad Sci; 2006 Oct; 1082():124-36. PubMed ID: 17145934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thermodynamics of DNA-RNA heteroduplex formation: effects of locked nucleic acid nucleotides incorporated into the DNA strand.
    Kaur H; Wengel J; Maiti S
    Biochemistry; 2008 Jan; 47(4):1218-27. PubMed ID: 18171024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.